A blockbuster AstraZeneca drug may now be used as an earlier treatment for mantle cell lymphoma (MCL), making ... for this rare and aggressive type of blood cancer. The FDA expanded approval ...

Feb. 5. 2025 – The FDA has approved a new pill to treat adults with a type of blood cancer called mantle cell lymphoma (MCL). This treatment is for people who are newly diagnosed or haven't h ...

Findings showed acalabrutinib with bendamustine and rituximab (BR) reduced the risk of disease progression or death by 27% compared with placebo plus BR. The Food and Drug Administration (FDA) has ...